Budget impact of treatment-free remission in Japanese CML patients based on frontline nilotinib data

Shinya Kimura

Presentation information

Oral Session

Oral Session 3-11B CML: Clinical (1)

Sun. Oct 13, 2019 10:10 AM - 11:10 AM No.11 (Tokyo International Forum, 5F G502)

Chair: Michihide Tokuhira (Department of Hematology, Saitama Medical Center, Saitama Medical University)

[OS3-11B-1] Budget impact of treatment-free remission in Japanese CML patients based on frontline nilotinib data

Shinya Kimura¹, Kiyotaka Yamazaki², Viana Ricardo³, Naohito Inagaki² (1.Hematol/Oncol, Saga Univ., Saga, Japan, 2.Novartis Pharma K.K. Tokyo, Japan, 3.Novartis Pharmaceuticals Corporation, New Jersey, USA)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.